New Study Reveals Muscle Loss Risks with GLP-1 Drugs in USA
June 24, 2025 – GLP-1 drugs such as Ozempic and Zepbound have gained popularity in the USA for their effective weight loss capabilities. While these medications help people reduce fat quickly, recent studies have revealed an unintended consequence: muscle loss.
Losing muscle can lead to weakness and other health complications. As a result, medical experts are now prioritizing strategies to help patients protect their muscle mass during GLP-1 treatment.
Key Recommendations for Patients Using GLP-1 Drugs
- Proper Diet: Nutrition tailored to support muscle maintenance.
- Strength Training: Incorporating resistance exercises to preserve muscle.
- Close Monitoring: Regular assessments of muscle health throughout treatment.
The study underscores the importance of balancing fat loss with muscle preservation to ensure overall well-being. Medical professionals strongly advise patients to:
- Consult their doctors before starting GLP-1 medications.
- Discuss personalized plans aimed at maintaining muscle strength.
This new focus on the side effects of GLP-1 drugs represents a significant advancement in improving patient care. For more updates, stay tuned to Questiqa USA.

Average Rating